Podcast: Download (Duration: 1:05 — 1.5MB)
Subscribe: RSS
Cardiovascular disease, including heart attacks and strokes, remains the number one cause of death in the United States, yet many people who should be taking medicines to lower their risk by lowering cholesterol aren’t. That’s according to a study by …
Podcast: Download (Duration: 1:05 — 1.5MB)
Subscribe: RSS
Most people have heard of statins, drugs that lower cholesterol and consequent cardiovascular disease risk. Caleb Alexander, a drug safety and efficacy expert at Johns Hopkins, and colleagues, have looked at just how many people who should be taking such …
Podcast: Download (Duration: 16:39 — 30.5MB)
Subscribe: RSS
Maddie Whalen, Evidence-Based Practice Program Coordinator for the Center for Nursing Inquiry joins Heather Watson, Johns Hopkins Health System Nurse Scientist to cover the Appendix E tools: E1, E2, E3. Appendix E includes appraisal templates for a variety of evidence …
Episode 68: Appendix E – 5th Edition (Part 6) | Johns Hopkins Center for Nursing Inquiry Read more »
Podcast: Download (Duration: 5:53 — 10.8MB)
Subscribe: RSS
We’re up to part 5 in our series – Appendix D, or the Appraisal Tool Selection Algorithm. Kim Bissett, EBP Coordinator for the Institute for Johns Hopkins Nursing is back to explain to Heather Watson, Nurse Scientist for the Johns …
Episode 67: Appendix D – 5th Edition (Part 5) | Johns Hopkins Center for Nursing Inquiry Read more »
Podcast: Download (Duration: 1:06 — 1.5MB)
Subscribe: RSS
Hot flashes and night sweats are called vasomotor symptoms, and they’re experienced by many women approaching menopause and those being treated for certain breast cancers. Now a new class of drugs has been developed to help. William Nelson, director of …
Podcast: Download (Duration: 1:05 — 1.5MB)
Subscribe: RSS
Women whose breast cancer has estrogen receptors are usually treated with estrogen depleting medicines, with the consequence that they have hot flashes and night sweats, so called ‘vasomotor symptoms,’ that many describe as worse than menopause. Now a new medicine …
